Moreover, by using the same techniques, Fiock and colleagues found that the number of astrocytes expressing MAPT and the amount of MAPT expressed by each astrocyte is comparable between patients affected by AD, CBD, PSP and healthy controls [80]. The gene discussed is MAPT; the disease is Alzheimer disease.